[Hub]/) : Traits : Heel T-Score :

chr12:14,220,891-16,190,627

Best TWAS P=7.55e-15 · Best GWAS P=2.67e-16 conditioned to 0.00179

Associated models

# Study Tissue Gene h2 eQTL R2 model # weights model R2 model R2 P eQTL GWAS Z TWAS Z TWAS P Top SNP corr PP3 PP4 joint
1 GTEx Adipose Subcutaneous ARHGDIB 0.10 0.01 enet 27 0.01 3.6e-02 -8.2 5.5 4.5e-08 -0.68 0.02 0.95 FALSE
2 GTEx Artery Aorta ARHGDIB 0.10 0.06 enet 10 0.08 5.4e-05 -6.5 6.4 1.3e-10 -0.83 0.33 0.56 FALSE
3 GTEx Artery Aorta C12orf60 0.16 0.10 lasso 6 0.13 1.4e-07 3.6 6.3 2.3e-10 -0.65 0.04 0.95 FALSE
4 GTEx Artery Tibial ARHGDIB 0.07 0.02 lasso 7 0.02 6.8e-03 -8.1 7.2 5.7e-13 -0.85 0.04 0.93 FALSE
5 GTEx Brain Nucleus accumbens basal ganglia RP11-174G6.5 0.23 0.13 lasso 4 0.11 8.9e-04 -4.5 6.3 2.4e-10 -0.77 0.03 0.87 FALSE
6 GTEx Nerve Tibial MGP 0.20 0.09 enet 35 0.10 9.7e-08 -8.1 5.7 1.4e-08 -0.74 0.03 0.97 FALSE
7 GTEx Nerve Tibial RERG 0.10 0.01 enet 18 0.01 7.3e-02 -1.6 5.4 5.7e-08 -0.47 0.04 0.66 FALSE
8 GTEx Thyroid MGP 0.11 0.04 enet 12 0.06 2.6e-05 -7.5 7.0 1.9e-12 -0.85 0.39 0.59 FALSE
9 GTEx Thyroid ARHGDIB 0.12 0.03 enet 20 0.02 7.4e-03 -7.8 7.8 7.6e-15 -0.83 0.06 0.89 TRUE
10 GTEx Thyroid C12orf60 0.16 0.10 enet 9 0.12 8.1e-10 3.3 5.8 5.1e-09 -0.62 0.78 0.22 FALSE
11 METSIM Adipose ERP27 0.07 0.04 blup 379 0.06 1.7e-09 -6.5 5.6 2.4e-08 -0.70 0.67 0.33 FALSE
12 METSIM Adipose MGP 0.04 0.04 bslmm 359 0.04 6.2e-07 -7.4 6.8 1.3e-11 -0.91 0.03 0.97 FALSE
13 NTR Blood ARHGDIB 0.01 0.00 blup 377 0.00 5.6e-02 -6.2 5.9 3.4e-09 -0.80 0.09 0.66 FALSE
14 YFS Blood ERP27 0.30 0.41 enet 31 0.42 3.1e-152 -5.8 6.3 3.5e-10 -0.83 1.00 0.00 FALSE
15 The Cancer Genome Atlas Bladder Urothelial Carcinoma ERP27 0.07 0.03 enet 17 0.04 1.6e-04 -5.9 5.5 4.7e-08 -0.66 0.20 0.49 FALSE
16 The Cancer Genome Atlas Breast Invasive Carcinoma ERP27 0.04 0.09 lasso 5 0.09 2.8e-17 -6.2 6.6 4.0e-11 -0.84 0.98 0.02 FALSE
17 The Cancer Genome Atlas Cervical Squamous Cell Carcinoma ERP27 0.09 0.14 lasso 2 0.12 1.7e-06 -6.2 6.3 3.2e-10 -0.81 0.30 0.68 FALSE
18 The Cancer Genome Atlas Esophageal Carcinoma ERP27 0.10 0.12 blup 75 0.08 1.5e-03 -5.8 6.6 5.5e-11 -0.85 0.04 0.78 FALSE
19 The Cancer Genome Atlas Glioblastoma Multiforme ERP27 0.18 0.07 blup 76 0.11 2.7e-04 -6.5 6.9 5.9e-12 -0.79 0.09 0.62 FALSE
20 The Cancer Genome Atlas Head and Neck Squamous Cell Carcinoma ERP27 0.10 0.18 lasso 6 0.18 1.2e-19 -6.4 6.5 7.0e-11 -0.86 0.96 0.04 FALSE
21 The Cancer Genome Atlas Brain Lower Grade Glioma ERP27 0.07 0.09 blup 73 0.09 4.8e-10 -5.8 6.0 1.5e-09 -0.85 0.79 0.21 FALSE
22 The Cancer Genome Atlas Lung Adenocarcinoma ERP27 0.15 0.28 lasso 6 0.28 8.3e-33 -6.2 6.4 2.0e-10 -0.81 1.00 0.00 FALSE
23 The Cancer Genome Atlas Lung Squamous Cell Carcinoma ERP27 0.17 0.24 enet 13 0.25 6.7e-28 -6.1 6.3 3.1e-10 -0.84 1.00 0.00 FALSE
24 The Cancer Genome Atlas Ovarian Serous Cystadenocarcinoma C12orf60 0.10 0.01 blup 56 0.07 1.6e-05 3.3 5.2 1.7e-07 -0.63 0.04 0.63 FALSE
25 The Cancer Genome Atlas Ovarian Serous Cystadenocarcinoma ERP27 0.04 0.05 enet 12 0.04 1.0e-03 -5.9 6.0 1.7e-09 -0.82 0.19 0.45 FALSE
26 The Cancer Genome Atlas Pheochromocytoma and Paraganglioma ERP27 0.14 0.12 lasso 5 0.11 2.9e-05 -6.2 6.2 6.2e-10 -0.80 0.22 0.65 FALSE
27 The Cancer Genome Atlas Prostate Adenocarcinoma ERP27 0.13 0.14 lasso 5 0.13 8.3e-14 -5.8 6.0 2.0e-09 -0.81 1.00 0.00 FALSE
28 The Cancer Genome Atlas Skin Cutaneous Melanoma ERP27 0.13 0.02 blup 74 0.06 1.4e-02 -6.4 6.8 7.2e-12 -0.82 0.03 0.65 FALSE
29 The Cancer Genome Atlas Stomach Adenocarcinoma ERP27 0.07 0.03 blup 76 0.07 1.5e-05 -2.0 5.7 1.6e-08 -0.70 0.07 0.91 FALSE
30 The Cancer Genome Atlas Testicular Germ Cell Tumors ERP27 0.10 0.05 lasso 1 0.08 8.9e-04 -6.2 6.2 4.3e-10 -0.81 0.20 0.57 FALSE
31 The Cancer Genome Atlas Thyroid Carcinoma ERP27 0.37 0.54 enet 18 0.55 2.3e-63 -6.2 6.6 5.6e-11 -0.83 1.00 0.00 FALSE